Onconetix, Inc.
Onconetix, Inc. (ONCO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ONCO · as of Jun 9, 2026
Key Statistics
Explore Onconetix, Inc. Data
onco stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
onco competitorsONCO
AZTR
ENVB
INDP
JSPR
PTIXStock Performance
Full HistoryAbout Onconetix, Inc.
Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The compa…
what is onconetix, inc. · onco stock overview · onconetix, inc. company profile · who is onconetix, inc. ceo · onco NASDAQ · onconetix, inc. headquarters · onconetix, inc. business segments
About Stock Overview & Key Data
Onconetix, Inc. (ONCO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 18, 2022. As of the latest trading session, ONCO stock price is $1.01, with a market capitalization of $337,369. The stock has returned -99.70% over the past 12 months and -98.71% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Onconetix, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Onconetix, Inc. reported revenue of $815371.00 and net income of -$14.0M. For detailed data — including Onconetix, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Onconetix, Inc. (ONCO) stock price is $1.01. The stock is traded on NASDAQ under the ticker symbol ONCO. The 52-week range is $0.91 – $382.50.